Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Asteatotic Eczema : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Multimedia
References

Related Articles
Cellulitis

Contact Dermatitis, Allergic

Contact Dermatitis, Irritant

Stasis Dermatitis

Thrombophlebitis




Patient Education
Skin, Hair, and Nails Center

Eczema Overview

Eczema Causes

Eczema Symptoms

Eczema Treatment




Author: Christina K Anderson, MD, Consulting Staff, Department of Dermatology, Centracare Clinic

Christina K Anderson is a member of the following medical societies: American Academy of Dermatology

Coauthor(s): O Fred Miller III, MD, Director, Department of Dermatology, Pennsylvania State Geisinger Medical Center; Susan Cooper, MRCGP, MRCP, MD, Consultant Dermatologist, Department of Dermatology, Churchill Hospital, Oxford, United Kingdom

Editors: Abby S Van Voorhees, MD, Assistant Professor, Director of Psoriasis Services and Phototherapy Units, Department of Dermatology, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania; Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center; Christen M Mowad, MD, Assistant Professor, Department of Dermatology, Geisinger Medical Center; Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University; William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System

Author and Editor Disclosure

Synonyms and related keywords: asteatotic dermatitis, eczema craquelé, eczema craquelatum, xerotic eczema, winter itch, eczema hiemalis, eczema fendille, etat craquelé

Background

First described by Brocq in 1907, using the term eczema craquelé, asteatotic dermatitis is characterized by pruritic, dry, cracked, and polygonally fissured skin with irregular scaling. It most commonly occurs on the shins of elderly patients, but it may occur on the hands and the trunk.

In 1971, Domonkos described the appearance of this dermatitis as cracked porcelain. The pattern of cracking has been likened to a crazy pavement pattern. In 1999, Fitzpatrick likened asteatotic eczema to a dried-up riverbed. According to Caplan, superficial bleeding and fissures can occur as the epidermis loses water, as it splits, and as it cracks deeply enough to disrupt papillary dermal capillaries. The inflammation can be associated with asymmetric leg edema. Eczema with increased lichenification occasionally supervenes as patients rub and scratch the pruritic areas.

The eruption can be generalized or localized. Generalized asteatosis is a distinct entity and should provoke a search for possible associated diseases. Guillet divides the localized forms into 4 types:

  • Asteatotic eczema of the lower extremities in elderly persons secondary to aging, dehydrated skin, and malnutrition
  • Cracked erythema secondary to irritant contact dermatitis from soaps or detergents
  • Eczema craquelé in areas in which corticosteroid therapy was discontinued
  • Asteatotic eczema in neurologic disorders

Pathophysiology

Initially, excess water loss from the epidermis results in dehydration of the stratum corneum with upward curling of corneocytes. The outer keratin layers require 10-20% water concentration to maintain their integrity. A significant decrease in free fatty acids in the stratum corneum is present in people with asteatotic dermatitis. Stratum corneum lipids act as water modulators, and cutaneous loss of these lipids can increase transepidermal water loss to 75 times that of healthy skin. Elderly persons with decreased sebaceous and sweat gland activity, patients on antiandrogen therapy, people using degreasing agents, and people bathing without replacing natural skin emollients lost to bath water are at risk for asteatotic eczema.

When the stratum corneum loses water, the cells shrink. A significantly decreased cellular volume can stress the skin's elasticity, creating fissures. Edema in the dermis leads to additional stretch on the overlying epidermis. Fissures rupture dermal capillaries, causing clinical bleeding. The disruption of cutaneous integrity can result in inflammation with risk of infection. Transepidermal absorption of allergens and irritants is increased as the epidermis is damaged, increasing susceptibility to allergic contact dermatitis and irritant contact dermatitis. Allergic contact dermatitis and irritant contact dermatitis may cause a persistent and possibly more extensive dermatitis despite therapy. Furthermore, low environmental humidity contributes to xerosis, creating a clinical picture of asteatotic dermatitis in some dermatologic conditions, such as atopic dermatitis.

Frequency

United States

Seasonality is prominent, and most patients present in the winter months, especially in areas where indoor humidity is decreased by heating. The frequency of asteatotic dermatitis is increased in the northern United States, particularly during the winter season.

Mortality/Morbidity

Although most cases resolve without ill effects, asteatotic dermatitis can be chronic with relapses frequent during the winter months and during times of low humidity.

Sex

Men older than 60 years develop asteatotic dermatitis more commonly than women.

Age

The median patient age at presentation is 69 years. Asteatosis can also occur in young people.



History

During the winter months, an elderly person classically presents with pruritic and dry skin with dermatitis on the pretibial areas. Sometimes, the dysesthesia may be described as a pinprick or biting sensation.

  • Asking the patient about pertinent controllable factors, such as the following, is important:
    • Frequency of bathing, showering, and cleansing, and which soaps and cleansers are in contact with the skin
    • Types of skin lubricants used, and method and frequency of application
    • Diet
    • Medications
    • Types of clothing worn (Wool may cause irritation.)
    • The source, the type, and the temperature of heat that may alter the humidity of the environment
  • If the eruption persists despite therapy, behavioral changes, and treatment compliance, allergic contact dermatitis and irritant contact dermatitis and internal malignancy may require investigation.

Physical

  • Primary lesions: Slightly scaly, inflamed, curvilinearly cracked and/or fissured skin most commonly involves the pretibial areas, but it may also occur on the thighs, on the hands, and on the trunk (see Image 1).
  • Secondary lesions
    • Excoriated, erythematous, edematous patches may result from rubbing or scratching.
    • Bleeding fissures secondary to the disruption of dermal capillaries have been described in exaggerated eczema craquelé, which begins as superficial cracks in the epidermis.
  • Generalized lesions: Generalized or extensive asteatotic dermatitis presents with primary lesions and secondary excoriations (see Images 2-3).

Causes

Multiple etiologic factors may coexist to cause asteatotic dermatitis, including the following:

  • Xerosis and friction
  • Frequent or prolonged bathing in hot water, use of soap on the involved site, and infrequent use of emollients for water retention in the stratum corneum
  • Degreasing agents
    • Solvents
    • Cleansers
  • Decreased sebaceous and sweat gland activity in elderly persons
  • Decreased keratin synthesis in elderly persons
  • Low environmental humidity and cold winds that increase the loss of water by convection
  • Radiation
  • Long-term malabsorption of essential fatty acids, including linoleic acid and linolenic acid
  • Nutritional deficiencies
    • Zinc deficiency
    • Essential fatty acid deficiency, such as linoleic acid deficiency or linolenic acid deficiency
  • Atopy
  • Ichthyosis
  • Thyroid disease - Myxedema and other thyroid diseases with diminished sweat and sebaceous gland activity
  • Neurologic disorders - Decreased sweating in denervated areas
  • Drugs - Antiandrogen therapy and diuretic therapy
  • Malignancies - Malignant lymphoma, gastric adenocarcinoma, glucagonoma, angioimmunoblastic lymphadenopathy, breast cancer, large-cell lung carcinoma, and colorectal carcinoma



Cellulitis
Contact Dermatitis, Allergic
Contact Dermatitis, Irritant
Stasis Dermatitis
Thrombophlebitis

Other Problems to be Considered

Nummular eczema



Lab Studies

  • Appropriate laboratory studies are indicated for identified or suspected associated diseases.

Histologic Findings

Spongiosis and a varying amount of inflammatory dermal infiltrate similar to that of mild, subacute eczema are seen.



Medical Care

Patients should follow the methods listed below to improve the condition.

  • Take short baths with decreased water temperature.
  • Eliminate or reduce the use of soap on the involved areas.
  • Avoid harsh skin cleansers.
  • Apply petrolatum-based emollients following bathing, and use moisturizing agents liberally.
  • Apply topical steroid ointments with or without polyethylene occlusion.
  • Use humidifiers.



Topical steroid ointments with 24- to 48-hour occlusion with polyethylene or Unna boots are the treatment of choice for the rapid resolution of asteatotic dermatitis. Many patients heal with mild topical steroids (class III-VI) alone, depending on the severity of the dermatitis, the patient's compliance with treatment, and the reduction in the use of soap and hot water to the involved areas. The liberal use of moisturizers, especially petrolatum-based preparations, alone or in combination with topical steroids for mild cases of asteatotic dermatitis is recommended.

The soak-and-smear method of hydrating the skin by bathing or soaking the affected area followed by immediate application of steroid ointment once daily has been shown to clear more that 90% of patients in 4-14 days. This is best performed at night.

Drug Category: Topical steroids

These agents have anti-inflammatory properties and cause profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.

Drug NameTriamcinolone acetonide (Aristocort)
DescriptionFor inflammatory dermatosis responsive to steroids; decreases inflammation by suppressing migration of polymorphonuclear leukocytes and reversing capillary permeability. Available in ointment (0.1%) and cream (0.025%, 0.1%, 0.5%).
Adult DoseApply thin film bid/tid to response
Pediatric DoseApply as in adults
ContraindicationsDocumented hypersensitivity; fungal, viral, and bacterial skin infections
InteractionsNone reported
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsProlonged use causes striae and atrophy; do not use in decreased skin circulation; prolonged use, applications over large areas, and use of potent steroids and occlusive dressings may result in systemic absorption; systemic absorption may cause Cushing syndrome, reversible HPA-axis suppression, hyperglycemia, and glycosuria



Deterrence/Prevention

Prognosis

  • Asteatotic dermatitis responds well to therapy; however, if the causative factors are not eliminated, recurrences are common.

Patient Education



Special Concerns

  • Be aware that nonhealing areas of asteatotic dermatitis may represent allergic contact dermatitis or irritant contact dermatitis. The rare generalized form should provoke a search for underlying malignancy.



Media file 1:  Asteatotic dermatitis on the lower extremity.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 2:  Asteatotic dermatitis on the lower extremity.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo

Media file 3:  Asteatotic dermatitis on the lower extremity.
Click to see larger pictureClick to see detailView Full Size Image
Media type:  Photo



  • Akimoto K, Yoshikawa N, Higaki Y, et al. Quantitative analysis of stratum corneum lipids in xerosis and asteatotic eczema. J Dermatol. Jan 1993;20(1):1-6. [Medline].
  • Barker DJ, Cotterill JA. Generalized eczema craquele as a presenting feature of lymphoma. Br J Dermatol. Sep 1977;97(3):323-6. [Medline].
  • Burton J, Holden C. Eczema, lichenification, and prurigo. In: Textbook of Dermatology. Vol 1. 6th ed. Oxford: Blackwell Science; 1998:. 644-45.
  • Caplan RM. Superficial hemorrhagic fissures of the skin. Arch Dermatol. Apr 1970;101(4):442-51. [Medline].
  • Cappiello L, Miller OF. Occlusive therapy of asteatotic dermatitis. Data presented at: Pennsylvania Academy of Dermatology. 1990.
  • Fitzpatrick T, Johnson R, Wolff K. Asteatotic Dermatitis. In: Color Atlas and Synopsis of Clinical Dermatology. 3rd ed. New York: McGraw-Hill; 1997:. 75.
  • Greist MC, Epinette WW. Cimetidine-induced xerosis and asteatotic dermatitis. Arch Dermatol. Apr 1982;118(4):253-4. [Medline].
  • Guillet MH, Schollhammer M, Sassolas B, Guillet G. Eczema craquele as a pointer of internal malignancy--a case report. Clin Exp Dermatol. Nov 1996;21(6):431-3. [Medline].
  • Gutman AB, Kligman AM, Sciacca J, James WD. Soak and smear: a standard technique revisited. Arch Dermatol. Dec 2005;141(12):1556-9. [Medline].
  • Higgins EM. Eczema craquele and internal malignancy. Clin Exp Dermatol. Jul 1997;22(4):206. [Medline].
  • Lazar AP, Lazar P. Dry skin, water, and lubrication. Dermatol Clin. Jan 1991;9(1):45-51. [Medline].
  • Murray H, Forsey RR. Eczema craquele. Arch Dermatol. 1975;111:1536.
  • Warin AP. Eczema craquele as the presenting feature of myxoedema. Br J Dermatol. Sep 1973;89(3):289-91. [Medline].
  • Weismann K, Wadskov S, Mikkelsen HI, et al. Acquired zinc deficiency dermatosis in man. Arch Dermatol. Oct 1978;114(10):1509-11. [Medline].
  • van Voorst Vader PC, Folkers E, van Rhenen DJ. Craquele-like eruption in angioimmunoblastic lymphadenopathy. Arch Dermatol. Mar 1979;115(3):370. [Medline].

Asteatotic Eczema excerpt

Article Last Updated: Oct 5, 2006